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Abstract  
The ongoing explosion of infections caused by antibiotic-resistant bacteria continues to 
challenge the global public health. However, the discovery and development of novel 
antibacterial drugs are on the decline in the past decades. Therefore, it is urgent to develop 
potent and safe antimicrobial agents. Here we report the chemical structure, biosynthesis and 
modes of action of a novel antimicrobial agent, paenibacterin, from a strain of Paenibacillus 
thiaminolyticus OSY-SE. The producer microorganism was isolated from a soil sample 
collected in Columbus, OH in 2011. The potent antimicrobial agent was extracted by 
acetonitrile from the producer cells and purified using HPLC. The core peptide structure of 
paenibacterin was elucidated by mass-spectrometry (MS) and nuclear magnetic resonance 
(NMR) while the lipid tail of compound was determined by GC-MS. In order to identify the 
biosynthetic pathway of the compound, the whole genome of the producer strain OSY-SE was 
sequenced using the high throughput Illumina sequencing technology. The paenibacterin gene 
cluster (pbt) was further identified by bioinformatic analyses and confirmed by in vitro protein 
functional analyses. Furthermore, the mechanisms of action of paenibacterin were studied by 
fluorescence microscopy, membrane integrity assays, and hydroxyl radical production assays. 
Paenibacterin is a broad-spectrum antimicrobial agent with potent activity against foodborne 
pathogens and clinical drug-resistant isolates. Paenibacterin generally yielded a minimum 
inhibitory concentration (MIC) at 2-8 μg/ml against Gram-negative strains, and 8-64 μg/ml 
2 
 
against Gram-positive strains. Paenibacterin is a cyclic lipopeptide, consisting of 13 amino 
acids and a C15 fatty acid side chain. Among the amino acids, some are D-amino acids and 
non-proteinogenic amino acid (ornithine). Paenibacterin is biosynthesized by the producer 
strain through non-ribosomal peptide synthetases (NRPS). The biosynthetic gene cluster was 
identified within 52-kb region, encoding three NRPSs (PbtA, PbtB and PbtC) and two 
ABC-transporters (PbtD and PbtE). Paenibacterin damages bacterial cell membrane, resulting 
in cytoplasmic membrane deporlarization and potassium ions release. Furthermore, 
paenibacterin triggers radical production via Fenton reaction and subsequently leads to cell 
death. This study reported a unique and potent antimicrobial agent with activity against 
drug-resistant bacteria. The structure of the compound could serve a scaffold for designing 
even more potent compounds by chemical synthesis. In addition, the elucidation of the 
biosynthetic pathway expedites the effort to produce paenibacterin derivatives by genetic 
engineering. This new and potent compound is a very promising candidate for agricultural and 
clinical application.    
Introduction 
There is a constant need for novel, safe and effective antimicrobial agents because 
bacterial can evolve rapidly and acquire resistance to antibiotics in use today. Bacterial natural 
products remain the important source of novel antibiotics with new scaffold and mechanism of 
action (Clardy, Fischbach, & Walsh, 2006). Since thousands of antibiotic compounds have 
been discovered from soil microorganisms (Clardy et al., 2006), new strategies should be used 
to combat the rediscovery of old antibiotics (Clardy et al., 2006; Fischbach & Walsh, 2009). In 
this study, we used two non-conventional media, soil-extract agar (Hamaki et al., 2005) and 
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dilute nutrient agar (Janssen, Yates, Grinton, Taylor, & Sait, 2002), to isolate new bacteria 
strains producing antibacterial agents. Using these new culturing media, a new isolate, 
designated as Paenibacillus thiaminolyticus OSY-SE, was found from a soil sample producing 
novel antimicrobial agent. The new compound, paenibacterin, exhibits antimicrobial activities 
against both Gram-positive and Gram-negative bacteria. 
Paenibacillus was originally classified under Bacillus and was reclassified as a new 
genus (Ash, Priest, & Collins, 1993). Paenibacillus spp. are spore-forming bacteria that are 
widely distributed in environments such as soil and plant root. Some species promote plant 
growth and nitrogen fixation (Khianngam, Akaracharanya, Tanasupawat, Lee, & Lee, 2009; 
McSpadden Gardener, 2004; Timmusk & Wagner, 1999; von der Weid, Duarte, van Elsas, & 
Seldin, 2002). A wide variety of antimicrobial agents, including lantibiotics (He et al., 2007), 
lipopeptides (Martin et al., 2003), and macrolide antibiotic (Wu et al., 2010) are produced by 
strains of Paenibacillus species.   
Structural Elucidation of Paenibacterin 
The antimicrobial agent was extracted from bacterial cells with acetonitrile, and 
purified using liquid chromatography. After analyses by mass spectrometry (MS) and nuclear 
magnetic resonance (NMR), the antimicrobial compound was determined to be a cyclic 
lipopeptide consisting of a C15 fatty acyl (FA) chain and thirteen amino acids. The deduced 
sequence is: FA-Orn-Val-Thr-Orn-Ser-Val-Lys-Ser-Ile-Pro-Val-Lys-Ile. The carboxyl terminal 
Ile is connected with Thr by an ester linkage (Figure 1). The new compound, designated as 
paenibacterin, showed activity against Gram-positive and Gram-negative bacteria, including 
Listeria monocytogenes, methicillin-resistant Staphylococcus aureus, Escherichia coli O157: 
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H7, and Salmonella enterica serovar Typhimurium. Paenibacterin is resistant to trypsin, lipase, 
α-glucosidase and lysozyme. But the compound is sensitive to pronase and polymyxin acylase. 
Paenibacterin is readily soluble in water, and fairly stable to exposure to heat and a wide range 
of pH values. 
 
Figure 1 The chemical structure of paenibacterin. 
Mechanism of action of Paenibacterin 
This study explored the mechanisms of action of paenibacterin against both 
Gram-positive and Gram-negative bacteria. Some Gram-negative bacteria are resistant to 
many antibiotics due to the permeability barrier of outer membrane (Vaara, 1992). The 
molecular basis of permeability lies in the lipopolysaccharide networks that are 
electrostatically linked by divalent cations (Mg
2+
 and Ca
2+
). Cationic agents and ion chelators 
are well-known permeabilizers that disorganize the outer membrane (Vaara, 1992). Cationic 
peptides, such as polymyxins, enter bacterial cells by a self-promoted uptake pathway 
(Hancock, 1997). A fluorescent-labeled polymyxin B (BODIPY FL conjugate, Invitrogen, 
Carlsbad, CA) was used to measure the binding affinity of paenibacterin to purified LPS from 
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E. coli O111: B4 and to the intact bacterial cells of E. coli ATCC 25922. In this study, we found 
that paenibacterin had high affinity to lipopolysaccharides. The interaction with 
lipopolysaccharides may displace the Mg
2+
 and Ca
2+ 
and promote the uptake of paenibacterin. 
The LPS binding ability of paenibacterin also suggested that paenibacterin can neutralize LPS 
and prevent endotoxinamia during antibiotic treatment (Hancock, 1997). As an outer 
membrane permeabilizer, the combination of paenibacterin with other antibiotics may show 
synergistic interaction against drug-resistant pathogens.  
        
        
Figure 2 BODIPY FL-labeled polymyxin B displacement assays.(A) in vitro polymyxin 
B-LPS displacement; (B) in vivo polymyxin B-cells displacement assay using E. coli.     
(B) 
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Figure 3 Effect of paenibacterin (paen), nisin vancomycin (van) and polymyxin E (pmx) on 
bacterial membrane potential. (A) S. aureus ATCC 6538 (B) E. coli ATCC 25922.  
The bacterial cytoplasmic membrane is the direct target of paenibacterin for 
Gram-positive and Gram-negative bacteria. The membrane potential assays were performed 
using a fluorescence probe, 3,3'-Dipropylthiadicarbocyanine Iodide (DiSC3(5)) (Invitrogen, 
Carlsbad, CA) according to previously reported method (Zhang, Dhillon, Yan, Farmer, & 
Hancock, 2000). Potassium ion release assays were performed using the cell impermeable 
K
+
-sensitive probe (PBFI, Invitrogen) (Silverman, Perlmutter, & Shapiro, 2003). Paenibacterin 
(A) 
(B) 
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depolarized cell membrane (Figure 3), triggered K
+
 release (Figure 4) and increased the 
uptake of propidium iodide (Figure 5). The cell membrane is essential to bacterial life as it 
contains one-third of proteins in a cell and is the place for crucial processes (Hurdle et al., 
2010). Therefore, by damaging the cell membrane, paenibacterin may interfere with numerous 
cellular functions such as function of electrical transport chain.  
 
            
         
Figure 4 Effect of paenibacterin (paen), nisin, vancomycin (van) and polymyxin E (pmx) on 
K
+
 release. (A) S. aureus ATCC 6538 (B) E. coli ATCC 25922.  
 
 
 
 
(A) 
(B) 
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 (A)                               (B)     
      
(C)                                (D)     
     
Figure 5 Effect of paenibacterin on bacterial cell membrane permeability. (A) Untreated cells 
of S. aureus ATCC 6538 (B) S. aureus ATCC 6538 treated with 80 μg/ml paenibacterin for 1hr; 
(C) untreated E. coli ATCC 25922 (D) E. coli ATCC 25922 treated with 64 μg/ml paenibacterin 
for 1 hr.    
 
Reactive oxygen species (ROS), such as superoxide and hydroxyl radicals, are highly 
deleterious to bacterial cells by oxidizing macromolecules such as DNA (Imlay, 2002; Imlay, 
2003). The hydroxyl radical levels were measured by the hydroxyl radical indicator, 
hydroxyphenyl fluorescein (HPF, Invitrogen) (Sampson et al., 2012). In addition to membrane 
damage, paenibacterin led to production of hydroxyl radicals in E. coli cells (Figure 6). 
Supporting the oxidative damage notion, we found that the radical scavenger, thiourea, 
partially protected cells from killing by paenibacterin. Also, pretreatment with the iron chelator 
dipyridyl reduced the killing effect of paenibacterin against E. coli (Figure 7). Kohanski et al. 
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(2010) pointed out that the drug-target interaction resulted in hyperactivation of electron 
transport chain and generation of superoxides (O2
-
) formation. Superoxide in turn damages the 
iron-sulfur cluster and thus releases ferrous irons, which stimulated the production of hydroxyl 
radical through Fenton reaction (Imlay, 2003; Kohanski et al., 2010).   
 
Figure 6 Hydroxyl radical production in paenibacterin treated cells of E. coli ATCC 25922.  
In this study, we presented the dual mechanisms of action of paenibacterin, namely 
direct cell membrane damage and indirect oxidative cellular damages due to hydroxyl radical 
formation. Unlike other conventional antibiotics, bacteria are more difficult to acquire 
resistance to membrane-active peptides (Hancock & Sahl, 2006; Hurdle et al., 2010).  
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Figure 7 Effect of dipyridyl (Dip, 450 μM) and thiourea (Thio, 100 mM) on the killing efficacy 
of paenibacterin (Pbt). (A) S. aureus ATCC 6538, Pbt at 96 μg/ml (B) E. coli ATCC 25922, Pbt 
at 64 μg/ml 
Biosynthesis of Paenibacterin 
To elucidate the biosynthesis of paenibacterin in Paenibacillus thiaminolyticus 
OSY-SE, we determined the whole genome sequence of the producer strain. The gene cluster 
for paenibacterin biosynthesis was identified within 52-kb region, encoding three 
non-ribosomal peptide synthetases (PbtA, PbtB and PbtC) and two ABC-transporters (PbtD 
and PbtE) (Table 1). As deduced from the sequence data, each PbtA and PbtB enzyme consists 
(A) 
(B) 
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of five modules, whereas PbtC is composed of three modules. Each of the 13 modules 
assembles one amino acid into the paenibacterin peptide (Figure 8).  
Table 1 The biosynthetic cluster in P. thiaminolyticus OSY-SE responsible for paenibacterin 
synthesis 
ORFs
a
 Bases 
number 
Amino acids 
number 
Calculated 
molecular mass 
(Dalton) 
Predicted function  
pbtA 19,818 6,605 745,827.1 Peptide synthetase 
pbtB 19,251 6,416 723,020.7 Peptide synthetase 
pbtC 9,513 3,170 356,884.2 Peptide synthetase 
pbtD 1,713 570 63,374.5 ABC transporter 
pbtE 1,749 582 64,584.7 ABC transporter 
a 
ORFs open reading frames 
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Figure 8: continued 
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Figure 1 Schematic overview of paenibacterin biosynthesis in P. thiaminolyticus OSY-SE. The 
peptide core is assembled by three NRPSs PbtA, PbtB, PbtC. 
 
Discussion 
 
Paenibacterin is a promising antibiotic scaffold for developing new antibiotics targeting 
drug-resistant pathogens. The mechanisms of action of paenibacterin involve direct cell 
membrane damage and indirect oxidative cellular damage. Paenibacterin is a cationic 
lipopeptide with four positive charges. The electrostatic interaction between paenibacterin and 
LPS can displace the divalent cations on the LPS network and promote the uptake of 
paenibacterin. The cytoplasmic membrane is the direct target of paenibacterin. Paenibacterin 
depolarized cell membrane, triggered K
+
 release and increased the uptake of hydrophobic 
nucleic acid stain, propidium iodide. In addition, paenibacterin led to production of hydroxyl 
Figure 8: continued 
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radicals in bacterial cells. The radical scavenger thiourea and the iron chelator dipyridyl 
reduced the killing effect of paenibacterin against Escherichia coli and Staphylococcus aureus. 
The presence of non-proteinogeneic amino acids (ornithine) in the peptide sequence 
suggested that paenibacterin is synthesized by nonribosomal synthetases. In order to determine 
the genes for paenibacterin biosynthesis, we sequenced the whole genome of the producer 
strain using the next-generation sequencing technology. The gene cluster was identified within 
52-kb region, encoding three non-ribosomal peptide synthetases (PbtA, PbtB and PbtC) and 
two ABC-transporters (PbtD and PbtE). As deduced from the sequence data, each PbtA and 
PbtB enzyme consists of five modules, whereas PbtC is composed of three modules. Each of 
the 13 modules assembles one amino acid into the paenibacterin peptide. Facing the challenges 
of antibiotic resistance, paenibacterin has the potential to become a new therapeutic approach 
against bacterial infections.  
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